Utility of Functional Imaging in Prediction or Assessment of Treatment Response and Prognosis Following Thermotherapy

Overview

Journal Int J Hyperthermia

Publisher Informa Healthcare

Specialties Oncology
Pharmacology

Date 2010 Feb 23

PMID 20170362

Citations 3

Authors

Mark W Dewhirst

Donald E Thrall

Gregory Palmer

Thies Schroeder

Zeljko Vujaskovic

H Cecil Charles

James MacFall

Terence Wong

Affiliations

Soon will be listed here.

Abstract

The purpose of this review is to examine the roles that functional imaging may play in prediction of treatment response and determination of overall prognosis in patients who are enrolled in thermotherapy trials, either in combination with radiotherapy, chemotherapy or both. Most of the historical work that has been done in this field has focused on magnetic resonance imaging/magnetic resonance spectroscopy (MRI/MRS) methods, so the emphasis will be there, although some discussion of the role that positron emission tomography (PET) might play will also be examined. New optical technologies also hold promise for obtaining low cost, yet valuable physiological data from optically accessible sites. The review is organised by traditional outcome parameters: local response, local control and progression-free or overall survival. Included in the review is a discussion of future directions for this type of translational work.

Citing Articles

Current Challenges in Image-Guided Magnetic Hyperthermia Therapy for Liver Cancer.

Sharma A, Cressman E, Attaluri A, Kraitchman D, Ivkov R Nanomaterials (Basel). 2022; 12(16).

PMID: 36014633 PMC: 9414548. DOI: 10.3390/nano12162768.

Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy.

Jordan B, Sonveaux P Front Pharmacol. 2012; 3:94.

PMID: 22661950 PMC: 3357106. DOI: 10.3389/fphar.2012.00094.

Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion.

Han D, Beasley G, Tyler D, Zager J Expert Opin Drug Metab Toxicol. 2011; 7(11):1383-94.

PMID: 21978383 PMC: 4630979. DOI: 10.1517/17425255.2011.609555.

References

Garman K, Nevins J, Potti A . Genomic strategies for personalized cancer therapy. Hum Mol Genet. 2007; 16 Spec No. 2:R226-32. DOI: 10.1093/hmg/ddm184. View

Brown J, Wilke L, Geradts J, Kennedy S, Palmer G, Ramanujam N . Quantitative optical spectroscopy: a robust tool for direct measurement of breast cancer vascular oxygenation and total hemoglobin content in vivo. Cancer Res. 2009; 69(7):2919-26. PMC: 2677720. DOI: 10.1158/0008-5472.CAN-08-3370. View

Brizel D, Schroeder T, Scher R, Walenta S, Clough R, Dewhirst M . Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001; 51(2):349-53. DOI: 10.1016/s0360-3016(01)01630-3. View

Hashimoto T, Hussien R, Oommen S, Gohil K, Brooks G . Lactate sensitive transcription factor network in L6 cells: activation of MCT1 and mitochondrial biogenesis. FASEB J. 2007; 21(10):2602-12. DOI: 10.1096/fj.07-8174com. View

Amthauer H, Denecke T, Rau B, Hildebrandt B, Hunerbein M, Ruf J . Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging. 2004; 31(6):811-9. DOI: 10.1007/s00259-003-1453-1. View

Turnbull L . Dynamic contrast-enhanced MRI in the diagnosis and management of breast cancer. NMR Biomed. 2008; 22(1):28-39. DOI: 10.1002/nbm.1273. View

Tarnawski R, Sokol M, Pieniazek P, Maciejewski B, Walecki J, Miszczyk L . 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys. 2002; 52(5):1271-6. DOI: 10.1016/s0360-3016(01)02769-9. View

Eschmann S, Paulsen F, Reimold M, Dittmann H, Welz S, Reischl G . Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med. 2005; 46(2):253-60. View

Yuan H, Schroeder T, Bowsher J, Hedlund L, Wong T, Dewhirst M . Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med. 2006; 47(6):989-98. View

10.

Liotta L, Mandler R, MURANO G, Katz D, Gordon R, Chiang P . Tumor cell autocrine motility factor. Proc Natl Acad Sci U S A. 1986; 83(10):3302-6. PMC: 323501. DOI: 10.1073/pnas.83.10.3302. View

11.

Zhou C, Choe R, Shah N, Durduran T, Yu G, Durkin A . Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy. J Biomed Opt. 2007; 12(5):051903. DOI: 10.1117/1.2798595. View

12.

Dressman H, Hans C, Bild A, Olson J, Rosen E, Marcom P . Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy. Clin Cancer Res. 2006; 12(3 Pt 1):819-26. DOI: 10.1158/1078-0432.CCR-05-1447. View

13.

Kukreti S, Cerussi A, Tromberg B, Gratton E . Intrinsic near-infrared spectroscopic markers of breast tumors. Dis Markers. 2009; 25(6):281-90. PMC: 2732199. DOI: 10.1155/2008/651308. View

14.

Prescott D, Charles H, Sostman H, Dodge R, Thrall D, Page R . Therapy monitoring in human and canine soft tissue sarcomas using magnetic resonance imaging and spectroscopy. Int J Radiat Oncol Biol Phys. 1994; 28(2):415-23. DOI: 10.1016/0360-3016(94)90065-5. View

15.

Walenta S, Chau T, Schroeder T, Lehr H, Kunz-Schughart L, Fuerst A . Metabolic classification of human rectal adenocarcinomas: a novel guideline for clinical oncologists?. J Cancer Res Clin Oncol. 2003; 129(6):321-6. DOI: 10.1007/s00432-003-0450-x. View

16.

Baur A, Stabler A, Wendtner C, Arbogast S, Rahman S, Santl M . MR-imaging changes of musculoskeletal soft-tissue sarcomas associated with neoadjuvant chemotherapy and hyperthermia. Int J Hyperthermia. 2003; 19(4):391-401. DOI: 10.1080/0265673021000058366. View

17.

Vishwanath K, Yuan H, Barry W, Dewhirst M, Ramanujam N . Using optical spectroscopy to longitudinally monitor physiological changes within solid tumors. Neoplasia. 2009; 11(9):889-900. PMC: 2735810. DOI: 10.1593/neo.09580. View

18.

Swanton C, Szallasi Z, Brenton J, Downward J . Functional genomic analysis of drug sensitivity pathways to guide adjuvant strategies in breast cancer. Breast Cancer Res. 2008; 10(5):214. PMC: 2614525. DOI: 10.1186/bcr2159. View

19.

Gooley T, Leisenring W, Crowley J, Storer B . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999; 18(6):695-706. DOI: 10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o. View

20.

Vaupel P, Okunieff P, Neuringer L . In vivo 31P-NMR spectroscopy of murine tumours before and after localized hyperthermia. Int J Hyperthermia. 1990; 6(1):15-31. DOI: 10.3109/02656739009140801. View